Traws Pharma, Inc.

DB:0T20 주식 보고서

시가총액: €13.8m

Traws Pharma 과거 수익 실적

과거 기준 확인 0/6

Traws Pharma's earnings have been declining at an average annual rate of -20.4%, while the Pharmaceuticals industry saw earnings growing at 13.1% annually. Revenues have been declining at an average rate of 58.1% per year.

주요 정보

-20.4%

수익 성장률

79.9%

EPS 성장률

Pharmaceuticals 산업 성장7.3%
매출 성장률-58.1%
자기자본 수익률-2,247.1%
순이익-60,641.2%
최근 수익 업데이트30 Jun 2024

최근 과거 실적 업데이트

Recent updates

수익 및 비용 분석

Traws Pharma 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.


수익 및 매출 내역

DB:0T20 수익, 비용 및 수입 (USD Millions )
날짜수익수익G+A 비용R&D 비용
30 Jun 240-1371011
31 Mar 240-18109
31 Dec 230-19911
30 Sep 230-20913
30 Jun 230-21814
31 Mar 230-21813
31 Dec 220-19811
30 Sep 220-1799
30 Jun 220-1598
31 Mar 220-1697
31 Dec 210-1697
30 Sep 210-19910
30 Jun 210-22913
31 Mar 210-25915
31 Dec 200-25817
30 Sep 200-24816
30 Jun 200-23816
31 Mar 202-19715
31 Dec 192-22715
30 Sep 192-21716
30 Jun 192-22716
31 Mar 191-23716
31 Dec 181-21817
30 Sep 181-21717
30 Jun 181-23718
31 Mar 181-21719
31 Dec 171-24719
30 Sep 171-23821
30 Jun 172-18919
31 Mar 174-21819
31 Dec 166-20920
30 Sep 1615-11819
30 Jun 1615-15820
31 Mar 1613-191022
31 Dec 1511-241026
30 Sep 152-411132
30 Jun 150-501238
31 Mar 150-571345
31 Dec 141-641549
30 Sep 143-651651
30 Jun 144-711955
31 Mar 144-681852
31 Dec 135-651750

양질의 수익: 0T20 is currently unprofitable.

이익 마진 증가: 0T20 is currently unprofitable.


잉여현금흐름 대 수익 분석


과거 수익 성장 분석

수익추이: 0T20 is unprofitable, and losses have increased over the past 5 years at a rate of 20.4% per year.

성장 가속화: Unable to compare 0T20's earnings growth over the past year to its 5-year average as it is currently unprofitable

수익 대 산업: 0T20 is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (28.7%).


자기자본 수익률

높은 ROE: 0T20 has a negative Return on Equity (-2247.07%), as it is currently unprofitable.


자산 수익률


고용 자본 수익률


과거 성과가 우수한 기업 찾기